Roche launches two new antibodies to identify key clinical mutations in patients with brain cancer
Recent advances in cancer genomics have deepened the medical community ’s understanding of the molecular alterations in braintumours, more preciselysubclassifying patients into specific diagnoses.Understanding a patient ' sbraintumour mutation status in the IDH1 and ATRX genes enables more informed clinical decisions and may improve patient outcomes.The IDH1 R132H and ATRX antibodies are the latest additions to Roche ’s neuropathology portfolio, which contains 29 biomarkers.Basel, 23 February 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the launch of the IDH1 R132H (MRQ-67) Rabbit Monoclonal Primary Antibo...
Source: Roche Media News - February 23, 2023 Category: Pharmaceuticals Source Type: news

Survival Lower for Children With Leukemia Living on Texas-Mexico Border
TUESDAY, Feb. 21, 2023 -- For children with acute lymphoblastic leukemia (ALL), but not those with acute myeloid leukemia (AML), living along the Texas-Mexico border is associated with inferior survival, according to a study published online Feb. 21... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 21, 2023 Category: Pharmaceuticals Source Type: news

Allogeneic Stem Cell Transplant Feasible for Leukemia in Elderly Patients
TUESDAY, Feb. 21, 2023 -- In elderly adults aged 60 years and older with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS), allogeneic hematopoietic stem cell transplant (HSCT) can be performed with acceptable overall survival and... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 21, 2023 Category: Pharmaceuticals Source Type: news

Targeted Agents Go Head-to-Head for Newly Diagnosed Ph+ ALL
(MedPage Today) -- In the first randomized comparison of targeted agents for acute lymphoblastic leukemia (ALL), ponatinib (Iclusig) prevailed over imatinib for untreated Philadelphia chromosome-positive (Ph+) cases. More than twice as many patients... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - February 16, 2023 Category: Hematology Source Type: news

Howard Bragman Dies: Public Relations And Crisis Management Expert, LGBTQ+ Activist Was 66
Howard Bragman, one of Hollywood’s top crisis management experts whose clients included Sharon Osbourne, Monica Lewinsky, Stevie Wonder, Chaz Bono and many more, died peacefully in his sleep Saturday night after a private battle with acute monocytic leukemia. He was 66, just days shy of his 67th…#howardbragman #hollywood #sharonosbourne #monicalewinsky #steviewonder #chazbono #universityofmichigan #bursonmarsteller #interpublicgroup #labreamedia (Source: Reuters: Health)
Source: Reuters: Health - February 12, 2023 Category: Consumer Health News Source Type: news

Poison with a purpose: a case report on arsenic cardiotoxicity and obesity - Nachtigal EA, Doan TN.
Acute promyelocytic leukemia (APL) is a form of leukemia in which there is an arrest of the maturation of the myeloid lineage at the promyelocyte stage. Although there is high early mortality due to coagulopathy, APL is now a curable disease with the use o... (Source: SafetyLit)
Source: SafetyLit - February 6, 2023 Category: International Medicine & Public Health Tags: Poisoning Source Type: news

Devastation as ‘extremely loved' three-year-old dies after battle with cancer
Porsha was diagnosed with acute myeloid leukaemia in September 2021 and has spent every day at the hospital since. (Source: Daily Express - Health)
Source: Daily Express - Health - February 4, 2023 Category: Consumer Health News Source Type: news

[Ad hoc announcement pursuant to Art. 53 LR] Roche reports good results for 2022 despite decline in demand for COVID-19 products
Basel, 2 February 2023Group sales grow by 2%1 at constant exchange rates (CER) and 1% in Swiss francs, despite lower COVID-19-related sales in both divisionsPharmaceuticals Division salesincrease by 2%; continued strong growth of newer medicines more than compensating for the impact of biosimilars and lower sales of Actemra/RoActemra (severe COVID-19)Diagnostics Division salesgrow by 3%; ongoing strong momentum in base business (+7%) more than compensating for the continuing decline in the demand for COVID-19 tests in the second half of the yearHighlightsin the fourth quarter of 2022 (incl. January 2023):US approvals ofLun...
Source: Roche Media News - February 2, 2023 Category: Pharmaceuticals Source Type: news

[Ad hoc announcement pursuant to Art. 53 LR] Roche reports good results for 2022 despite decline in demand for COVID-19 products
Group sales grow by 2%1 at constant exchange rates (CER) and 1% in Swiss francs, despite lower COVID-19-related sales in both divisionsPharmaceuticals Division salesincrease by 2%; continued strong growth of newer medicines more than compensating for the impact of biosimilars and lower sales of Actemra/RoActemra (severe COVID-19)Diagnostics Division salesgrow by 3%; ongoing strong momentum in base business (+7%) more than compensating for the continuing decline in the demand for COVID-19 tests in the second half of the yearHighlightsin the fourth quarter of 2022 (incl. January 2023):US approvals ofLunsumio (follicular lymp...
Source: Roche Investor Update - February 2, 2023 Category: Pharmaceuticals Source Type: news

Survival Outcomes in Young ALL Vary by Race/Ethnicity
(MedPage Today) -- While survival outcomes for children and young adults with acute lymphocytic leukemia (ALL) have improved significantly over the last several decades, substantial differences in outcomes by race and ethnicity continue to persist... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - February 1, 2023 Category: American Health Source Type: news

Inflammation Linked to Inferior Outcomes in Leukemia
WEDNESDAY, Jan. 18, 2023 -- A unique inflammation signature, in which atypical B cells are identified, is associated with worse outcomes in patients with acute myeloid leukemia (AML), according to a study published online Jan. 11 in Nature... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 18, 2023 Category: Pharmaceuticals Source Type: news

Blood Test 24 Hours After Starting Chemo Predicts AML Survival Blood Test 24 Hours After Starting Chemo Predicts AML Survival
Protein changes in peripheral blood samples in the first 24 hours after starting chemotherapy could predict which patients with acute myeloid leukemia respond.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 18, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Congenital CMV Linked to Pediatric Hyperdiploid ALL Congenital CMV Linked to Pediatric Hyperdiploid ALL
Early congenital cytomegalovirus could be a modifiable risk factor for childhood hyperdiploid acute lymphoblastic leukemia but more research delineating a mechanism is warranted.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 13, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

This little-known pharma stock can rally more than 60% in 2023, JPMorgan says
A promising treatment for acute leukemia makes Syndax Pharmaceuticals an attractive stock, JPMorgan said. Analyst Anupam Rama initiated coverage of Syndax with an overweight rating ahead of what could be significant new data on the company's cancer therapy called revumenib. "Our Overweight rating…#jpmorgan #rama #anupamrama #sndx #syndax #augment101 #michaelbloom (Source: Reuters: Health)
Source: Reuters: Health - January 4, 2023 Category: Consumer Health News Source Type: news

Shiba inu who inspired'doge' meme is seriously ill with leukemia | Business
Kabosu, the internet-famous dog who inspired the “doge” meme and influenced digital culture for a decade, is seriously ill with leukemia and liver disease. The 17-year-old shiba inu stopped “eating and drinking voluntarily” on Christmas Eve, and has been diagnosed with acute cholangiohepatitis and…#elonmusk #sakura #sans #stockholm #ministryofdefense #sato #kabosu #atsukosato #dogecoin #oreo (Source: Reuters: Health)
Source: Reuters: Health - December 28, 2022 Category: Consumer Health News Source Type: news